Introduction: The most recent guidelines vary in their approach to the management of
variceal bleeding especially with the use of endoscopic sclerotherapy (ES) and endoscopic …

Background Approximately 40% to 95% of people with liver cirrhosis have oesophageal
varices. About 15% to 20% of oesophageal varices bleed within about one to three years …

We performed a systematic review and meta-analysis of published studies to assess the
efficacy, safety, and outcomes of N-butyl cyanoacrylate (NBCA) injection for the treatment of …

Cirrhosis is a progressive disease that impairs liver function and decreases life expectancy.
1 The prognosis of patients with cirrhosis is highly dependent on the presence or not of …

Despite advances in the management of complications of portal hypertension, variceal
bleeding continues to be associated with significant morbidity and mortality. While …

Liver cirrhosis arises from liver fibrosis and necroinflammation caused by various
mechanisms of hepatic injury. It is a prevalent condition in clinical practice characterized by …

Objective This study aimed to compare the long-term outcome of endotherapy versus a
combination of splenectomy and devascularization for variceal bleeding in patients with …

Objective. To identify simple and accurate pre‐endoscopy risk factors for early identification
of high‐risk upper gastrointestinal bleeding. Methods. Patients who were admitted to …

Background and Objectives: ABO blood types have been implicated as potential risk factors
for various hemorrhagic diseases. No study has investigated the association between …

Duodenal varices are an uncommon presentation of portal hypertension and can result in
significant gastrointestinal bleeding with a high mortality. Diagnosis can be difficult and …